News
Swiss pharma giant Roche announced positive five-year efficacy, safety and durability data from the Phase III Portal study, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback